VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q56374917 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000154.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q56374917‏
024 ‎‡a 0000-0002-1914-9601‏ ‎‡2 orcid‏
024 ‎‡a 55368694100‏ ‎‡2 scopus‏
024 ‎‡a 8502315100‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q56374917‏
100 0 ‎‡a Charles R Brown‏ ‎‡9 es‏ ‎‡9 sl‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a চার্লস আর ব্রাউন‏ ‎‡9 bn‏
400 0 ‎‡a Charles R. Brown‏ ‎‡c American veterinary pathology researcher‏ ‎‡9 en‏
400 0 ‎‡a Charles R Brown‏ ‎‡c onderzoeker‏ ‎‡9 nl‏
670 ‎‡a Author's 5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis‏
670 ‎‡a Author's A paradoxical role for neutrophils in the pathogenesis of West Nile virus‏
670 ‎‡a Author's Adenoviral delivery of interleukin-10 fails to attenuate experimental Lyme disease‏
670 ‎‡a Author's Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease‏
670 ‎‡a Author's Black Walnut (Juglans nigra) Extracts Inhibit Proinflammatory Cytokine Production From Lipopolysaccharide-Stimulated Human Promonocytic Cell Line U-937‏
670 ‎‡a Author's Bone-marrow chimeras reveal hemopoietic and nonhemopoietic control of resistance to experimental Lyme arthritis‏
670 ‎‡a Author's Borrelia burgdorferi infection induces lipid mediator production during Lyme arthritis‏
670 ‎‡a Author's Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague‏
670 ‎‡a Author's CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice‏
670 ‎‡a Author's Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17‏
670 ‎‡a Author's Development of lyme arthritis in mice deficient in inducible nitric oxide synthase.‏
670 ‎‡a Author's Dietary fish oil substitution alters the eicosanoid profile in ankle joints of mice during Lyme infection‏
670 ‎‡a Author's Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plague‏
670 ‎‡a Author's Genes outside the major histocompatibility complex control resistance and susceptibility to experimental Lyme arthritis.‏
670 ‎‡a Author's Identification and Quantification of Bioactive Molecules Inhibiting Pro-inflammatory Cytokine Production in Spent Coffee Grounds Using Metabolomics Analyses‏
670 ‎‡a Author's Immunogenetics influence outcome of Toxoplasma gondii infection.‏
670 ‎‡a Author's In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain‏
670 ‎‡a Author's Increasing the Recruitment of Neutrophils to the Site of Infection Dramatically Attenuates Borrelia burgdorferi Infectivity‏
670 ‎‡a Author's Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.‏
670 ‎‡a Author's Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis‏
670 ‎‡a Author's Macrophage LTB4 drives efficient phagocytosis of Borrelia burgdorferi via BLT1 or BLT2.‏
670 ‎‡a Author's Macrophage Polarization during Murine Lyme Borreliosis.‏
670 ‎‡a Author's Omega-3 polyunsaturated fatty acid impairment of early host resistance against Listeria monocytogenes infection is independent of neutrophil infiltration and function‏
670 ‎‡a Author's Phagocytes and humoral immunity to pneumonic plague‏
670 ‎‡a Author's Rapid induction of inflammatory lipid mediators by the inflammasome in vivo‏
670 ‎‡a Author's Serum amyloid A-activating factor-1 (SAF-1) transgenic mice are prone to develop a severe form of inflammation-induced arthritis‏
670 ‎‡a Author's Stat1 deficiency exacerbates carditis but not arthritis during experimental lyme borreliosis‏
670 ‎‡a Author's Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2.‏
670 ‎‡a Author's T Cells Exacerbate Lyme Borreliosis in TLR2-Deficient Mice‏
670 ‎‡a Author's Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation‏
670 ‎‡a Author's The chemokine receptor CXCR2 ligand KC‏
670 ‎‡a Author's The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.‏
670 ‎‡a Author's The identification of a sequence related to apicomplexan enolase from Sarcocystis neurona.‏
670 ‎‡a Author's The role of eicosanoids in experimental Lyme arthritis.‏
670 ‎‡a Author's Treatment of Borrelia burgdorferi-Infected Mice with Apoptotic Cells Attenuates Lyme Arthritis via PPAR-γ‏
909 ‎‡a (orcid) 0000000219149601‏ ‎‡9 1‏
909 ‎‡a (scopus) 55368694100‏ ‎‡9 1‏
909 ‎‡a (scopus) 8502315100‏ ‎‡9 1‏
919 ‎‡a cyclooxygenase1orchestratesgerminalcenterformationandantibodyclassswitchviaregulationofil17‏ ‎‡A Cyclooxygenase-1 orchestrates germinal center formation and antibody class-switch via regulation of IL-17‏ ‎‡9 1‏
919 ‎‡a 5lipoxygenasedeficientmiceinfectedwithborreliaburgdorferideveloppersistentarthritis‏ ‎‡A 5-Lipoxygenase-deficient mice infected with Borrelia burgdorferi develop persistent arthritis‏ ‎‡9 1‏
919 ‎‡a paradoxicalroleforneutrophilsinthepathogenesisofwestnilevirus‏ ‎‡A A paradoxical role for neutrophils in the pathogenesis of West Nile virus‏ ‎‡9 1‏
919 ‎‡a adenoviraldeliveryofinterleukin10failstoattenuateexperimentallymedisease‏ ‎‡A Adenoviral delivery of interleukin-10 fails to attenuate experimental Lyme disease‏ ‎‡9 1‏
919 ‎‡a arthritisdevelopsbutfailstoresolveduringinhibitionofcyclooxygenase2inamurinemodeloflymedisease‏ ‎‡A Arthritis develops but fails to resolve during inhibition of cyclooxygenase 2 in a murine model of Lyme disease‏ ‎‡9 1‏
919 ‎‡a blackwalnutjuglansnigraextractsinhibitproinflammatorycytokineproductionfromlipopolysaccharidestimulatedhumanpromonocyticcelllineu937‏ ‎‡A Black Walnut (Juglans nigra) Extracts Inhibit Proinflammatory Cytokine Production From Lipopolysaccharide-Stimulated Human Promonocytic Cell Line U-937‏ ‎‡9 1‏
919 ‎‡a bonemarrowchimerasrevealhemopoieticandnonhemopoieticcontrolofresistancetoexperimentallymearthritis‏ ‎‡A Bone-marrow chimeras reveal hemopoietic and nonhemopoietic control of resistance to experimental Lyme arthritis‏ ‎‡9 1‏
919 ‎‡a borreliaburgdorferiinfectioninduceslipidmediatorproductionduringlymearthritis‏ ‎‡A Borrelia burgdorferi infection induces lipid mediator production during Lyme arthritis‏ ‎‡9 1‏
919 ‎‡a chemokinereceptorcxcr2mediatesbacterialclearanceratherthanneutrophilrecruitmentinamurinemodelofpneumonicplague‏ ‎‡A Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague‏ ‎‡9 1‏
919 ‎‡a cxcr2mediatesbrucellainducedarthritisininterferonγdeficientmice‏ ‎‡A CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice‏ ‎‡9 1‏
919 ‎‡a developmentoflymearthritisinmicedeficientininduciblenitricoxidesynthase‏ ‎‡A Development of lyme arthritis in mice deficient in inducible nitric oxide synthase.‏ ‎‡9 1‏
919 ‎‡a dietaryfishoilsubstitutionalterstheeicosanoidprofileinanklejointsofmiceduringlymeinfection‏ ‎‡A Dietary fish oil substitution alters the eicosanoid profile in ankle joints of mice during Lyme infection‏ ‎‡9 1‏
919 ‎‡a earlyapoptosisofmacrophagesmodulatedbyinjectionofyersiniapestisyopkpromotesprogressionofprimarypneumonicplague‏ ‎‡A Early apoptosis of macrophages modulated by injection of Yersinia pestis YopK promotes progression of primary pneumonic plague‏ ‎‡9 1‏
919 ‎‡a genesoutsidethemajorhistocompatibilitycomplexcontrolresistanceandsusceptibilitytoexperimentallymearthritis‏ ‎‡A Genes outside the major histocompatibility complex control resistance and susceptibility to experimental Lyme arthritis.‏ ‎‡9 1‏
919 ‎‡a identificationandquantificationofbioactivemoleculesinhibitingproinflammatorycytokineproductioninspentcoffeegroundsusingmetabolomicsanalyses‏ ‎‡A Identification and Quantification of Bioactive Molecules Inhibiting Pro-inflammatory Cytokine Production in Spent Coffee Grounds Using Metabolomics Analyses‏ ‎‡9 1‏
919 ‎‡a immunogeneticsinfluenceoutcomeoftoxoplasmagondiiinfection‏ ‎‡A Immunogenetics influence outcome of Toxoplasma gondii infection.‏ ‎‡9 1‏
919 ‎‡a invitrocorrelatesofldrestrictedresistancetotoxoplasmicencephalitisandtheircriticaldependenceonparasitestrain‏ ‎‡A In vitro correlates of Ld-restricted resistance to toxoplasmic encephalitis and their critical dependence on parasite strain‏ ‎‡9 1‏
919 ‎‡a increasingtherecruitmentofneutrophilstothesiteofinfectiondramaticallyattenuatesborreliaburgdorferiinfectivity‏ ‎‡A Increasing the Recruitment of Neutrophils to the Site of Infection Dramatically Attenuates Borrelia burgdorferi Infectivity‏ ‎‡9 1‏
919 ‎‡a infectionofinterleukin17receptoradeficientc3hmicewithborreliaburgdorferidoesnotaffecttheirdevelopmentoflymearthritisandcarditis‏ ‎‡A Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.‏ ‎‡9 1‏
919 ‎‡a lipidomicanalysisofdynamiceicosanoidresponsesduringtheinductionandresolutionoflymearthritis‏ ‎‡A Lipidomic analysis of dynamic eicosanoid responses during the induction and resolution of Lyme arthritis‏ ‎‡9 1‏
919 ‎‡a macrophageltb4drivesefficientphagocytosisofborreliaburgdorferiviablt1orblt2‏ ‎‡A Macrophage LTB4 drives efficient phagocytosis of Borrelia burgdorferi via BLT1 or BLT2.‏ ‎‡9 1‏
919 ‎‡a macrophagepolarizationduringmurinelymeborreliosis‏ ‎‡A Macrophage Polarization during Murine Lyme Borreliosis.‏ ‎‡9 1‏
919 ‎‡a Omega 3polyunsaturatedfattyacidimpairmentofearlyhostresistanceagainstlisteriamonocytogenesinfectionisindependentofneutrophilinfiltrationandfunction‏ ‎‡A Omega-3 polyunsaturated fatty acid impairment of early host resistance against Listeria monocytogenes infection is independent of neutrophil infiltration and function‏ ‎‡9 1‏
919 ‎‡a phagocytesandhumoralimmunitytopneumonicplague‏ ‎‡A Phagocytes and humoral immunity to pneumonic plague‏ ‎‡9 1‏
919 ‎‡a rapidinductionofinflammatorylipidmediatorsbytheinflammasomeinvivo‏ ‎‡A Rapid induction of inflammatory lipid mediators by the inflammasome in vivo‏ ‎‡9 1‏
919 ‎‡a serumamyloidaactivatingfactor1saf1transgenicmicearepronetodevelopasevereformofinflammationinducedarthritis‏ ‎‡A Serum amyloid A-activating factor-1 (SAF-1) transgenic mice are prone to develop a severe form of inflammation-induced arthritis‏ ‎‡9 1‏
919 ‎‡a stat1deficiencyexacerbatescarditisbutnotarthritisduringexperimentallymeborreliosis‏ ‎‡A Stat1 deficiency exacerbates carditis but not arthritis during experimental lyme borreliosis‏ ‎‡9 1‏
919 ‎‡a susceptibilitytoexperimentallymearthritiscorrelateswithkcandmonocytechemoattractantprotein1productioninjointsandrequiresneutrophilrecruitmentviacxcr2‏ ‎‡A Susceptibility to experimental Lyme arthritis correlates with KC and monocyte chemoattractant protein-1 production in joints and requires neutrophil recruitment via CXCR2.‏ ‎‡9 1‏
919 ‎‡a tcellsexacerbatelymeborreliosisintlr2deficientmice‏ ‎‡A T Cells Exacerbate Lyme Borreliosis in TLR2-Deficient Mice‏ ‎‡9 1‏
919 ‎‡a temporalroleformyd88inamodelofbrucellainducedarthritisandmusculoskeletalinflammation‏ ‎‡A Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation‏ ‎‡9 1‏
919 ‎‡a chemokinereceptorcxcr2ligandkc‏ ‎‡A The chemokine receptor CXCR2 ligand KC‏ ‎‡9 1‏
919 ‎‡a chemokinereceptorcxcr2ligandkccxcl1mediatesneutrophilrecruitmentandiscriticalfordevelopmentofexperimentallymearthritisandcarditis‏ ‎‡A The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.‏ ‎‡9 1‏
919 ‎‡a identificationofasequencerelatedtoapicomplexanenolasefromsarcocystisneurona‏ ‎‡A The identification of a sequence related to apicomplexan enolase from Sarcocystis neurona.‏ ‎‡9 1‏
919 ‎‡a roleofeicosanoidsinexperimentallymearthritis‏ ‎‡A The role of eicosanoids in experimental Lyme arthritis.‏ ‎‡9 1‏
919 ‎‡a treatmentofborreliaburgdorferiinfectedmicewithapoptoticcellsattenuateslymearthritisviapparγ‏ ‎‡A Treatment of Borrelia burgdorferi-Infected Mice with Apoptotic Cells Attenuates Lyme Arthritis via PPAR-γ‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 RERO|A003048750
996 ‎‡2 ISNI|0000000071403019
996 ‎‡2 LC|no 00075972
996 ‎‡2 BNF|12187851
996 ‎‡2 NDL|00981510
996 ‎‡2 LC|n 84026514
996 ‎‡2 ISNI|0000000043857056
996 ‎‡2 DNB|1233902903
996 ‎‡2 NII|DA08730583
996 ‎‡2 NUKAT|n 2009126378
996 ‎‡2 ISNI|0000000399406774
996 ‎‡2 PLWABN|9813698183405606
996 ‎‡2 J9U|987007423912305171
996 ‎‡2 ISNI|000000037736469X
996 ‎‡2 J9U|987007549471505171
996 ‎‡2 BNF|14159527
996 ‎‡2 LC|nr 93036533
996 ‎‡2 NTA|072585110
996 ‎‡2 ISNI|0000000031074484
996 ‎‡2 BNF|13943873
996 ‎‡2 NKC|ctu2013743491
996 ‎‡2 BNF|12192667
996 ‎‡2 NKC|xx0152365
996 ‎‡2 J9U|987007448857905171
996 ‎‡2 LC|n 79000334
996 ‎‡2 ISNI|0000000110668125
996 ‎‡2 LC|no2013128311
996 ‎‡2 BIBSYS|90691496
996 ‎‡2 ISNI|0000000041708778
996 ‎‡2 ISNI|0000000049472448
996 ‎‡2 NKC|xx0135787
996 ‎‡2 LC|n 87873351
996 ‎‡2 ISNI|0000000081176462
996 ‎‡2 CAOONL|ncf11221738
996 ‎‡2 NII|DA06133674
996 ‎‡2 SUDOC|069189129
996 ‎‡2 LC|n 83230853
996 ‎‡2 PTBNP|253198
996 ‎‡2 ISNI|0000000048693775
996 ‎‡2 LC|no2015141484
996 ‎‡2 NII|DA04689240
996 ‎‡2 NLA|000035916429
996 ‎‡2 NII|DA02579638
996 ‎‡2 LC|nb2022008389
996 ‎‡2 NTA|100824242
996 ‎‡2 ISNI|000000004640727X
996 ‎‡2 ISNI|0000000109288707
996 ‎‡2 LC|n 50039628
996 ‎‡2 BIBSYS|90537004
996 ‎‡2 ISNI|0000000110348439
996 ‎‡2 ISNI|0000000110383787
996 ‎‡2 BNF|12861237
996 ‎‡2 J9U|987007276285705171
996 ‎‡2 J9U|987007341537005171
996 ‎‡2 ISNI|0000000033588286
996 ‎‡2 NII|DA12241092
996 ‎‡2 NII|DA14837898
996 ‎‡2 NTA|074768603
996 ‎‡2 DNB|134965884
996 ‎‡2 LC|n 2024042370
996 ‎‡2 LC|n 82146633
996 ‎‡2 ISNI|0000000081775377
996 ‎‡2 ISNI|0000000047789214
996 ‎‡2 PLWABN|9811451441605606
996 ‎‡2 BIBSYS|12002228
996 ‎‡2 LC|no2009135437
996 ‎‡2 RERO|A012424720
996 ‎‡2 LC|n 83018636
996 ‎‡2 LC|n 83162138
996 ‎‡2 ISNI|0000000066986491
996 ‎‡2 SUDOC|182722643
996 ‎‡2 LC|no2017016503
996 ‎‡2 ISNI|0000000026646070
996 ‎‡2 ICCU|RMSV745896
996 ‎‡2 LC|n 82165375
996 ‎‡2 LC|no2003119360
996 ‎‡2 LC|n 2002074292
996 ‎‡2 ISNI|0000000436053307
996 ‎‡2 LC|no2010067585
996 ‎‡2 DNB|1244176664
996 ‎‡2 NLA|000035887961
996 ‎‡2 LC|nr2003017519
996 ‎‡2 SUDOC|221503056
996 ‎‡2 J9U|987007434320305171
996 ‎‡2 LC|n 2013046159
996 ‎‡2 NTA|292665601
996 ‎‡2 NUKAT|n 2019025530
996 ‎‡2 ISNI|0000000051398005
996 ‎‡2 ISNI|0000000042324696
996 ‎‡2 LC|n 2003019154
996 ‎‡2 BIBSYS|90063391
996 ‎‡2 SUDOC|200143352
996 ‎‡2 PLWABN|9810667900605606
996 ‎‡2 LC|n 79021137
996 ‎‡2 ISNI|0000000396717905
996 ‎‡2 ISNI|0000000046358260
996 ‎‡2 LC|no2010176428
996 ‎‡2 BNF|14026479
996 ‎‡2 BNE|XX977726
996 ‎‡2 NDL|00463849
996 ‎‡2 RERO|A005674596
996 ‎‡2 NTA|069092559
996 ‎‡2 DNB|174189818
996 ‎‡2 ISNI|0000000114738733
996 ‎‡2 SUDOC|194891364
996 ‎‡2 BNF|13594315
996 ‎‡2 BIBSYS|90728603
996 ‎‡2 LC|n 2008161587
996 ‎‡2 LC|no2018157148
996 ‎‡2 ISNI|0000000103845832
996 ‎‡2 ISNI|0000000114528330
996 ‎‡2 DNB|142992526
996 ‎‡2 LC|n 94011842
996 ‎‡2 ISNI|0000000430320881
996 ‎‡2 ISNI|0000000039085962
996 ‎‡2 RERO|A003047938
996 ‎‡2 DNB|170113663
996 ‎‡2 CAOONL|ncf10261316
996 ‎‡2 LC|n 2006056759
996 ‎‡2 BLBNB|001449513
996 ‎‡2 CAOONL|ncf10090011
996 ‎‡2 LC|n 98087032
996 ‎‡2 LC|n 81052088
996 ‎‡2 DNB|138735468
996 ‎‡2 LC|n 84004866
996 ‎‡2 W2Z|9062911
996 ‎‡2 LC|n 78027063
996 ‎‡2 LC|no2008185343
996 ‎‡2 NUKAT|n 2016006990
996 ‎‡2 NSK|000616296
996 ‎‡2 ISNI|0000000027193608
996 ‎‡2 BIBSYS|90074289
996 ‎‡2 LC|no 97037304
996 ‎‡2 BNF|12424201
996 ‎‡2 NTA|11876215X
996 ‎‡2 ISNI|0000000061560862
996 ‎‡2 LC|n 2009163460
996 ‎‡2 NKC|stk2007383304
996 ‎‡2 NUKAT|n 2010132310
996 ‎‡2 NTA|070762953
996 ‎‡2 BNF|12076910
996 ‎‡2 ISNI|0000000374504669
996 ‎‡2 NDL|00434521
996 ‎‡2 NII|DA14186519
996 ‎‡2 RERO|A003047929
996 ‎‡2 NUKAT|n 2010049331
996 ‎‡2 RERO|A003047923
996 ‎‡2 NII|DA04371795
996 ‎‡2 BIBSYS|90075251
996 ‎‡2 ISNI|0000000026425796
996 ‎‡2 DNB|124988504
996 ‎‡2 LC|n 95120392
996 ‎‡2 BNE|XX1267024
996 ‎‡2 NLA|000036015959
996 ‎‡2 BIBSYS|9062911
996 ‎‡2 BIBSYS|90122600
996 ‎‡2 BNCHL|10000000000000000254426
996 ‎‡2 NTA|087258102
996 ‎‡2 BNF|12279429
996 ‎‡2 LC|nr 98008380
996 ‎‡2 LC|no2007017946
996 ‎‡2 NII|DA00662195
996 ‎‡2 J9U|987007450814005171
996 ‎‡2 BNF|15679964
996 ‎‡2 LC|n 83194503
996 ‎‡2 LC|n 96032247
996 ‎‡2 LC|n 2018071839
996 ‎‡2 NII|DA05024913
996 ‎‡2 LC|no 99012585
996 ‎‡2 ISNI|0000000053544803
996 ‎‡2 LC|n 82043856
996 ‎‡2 J9U|987007460244305171
996 ‎‡2 LIH|LNB:B1_v__l_;=B1
996 ‎‡2 BIBSYS|2007917
996 ‎‡2 CAOONL|ncf10102523
996 ‎‡2 DBC|87097919326101
996 ‎‡2 LC|n 93036878
996 ‎‡2 BIBSYS|5000735
996 ‎‡2 LIH|LNB:C_n__f__k_;=CM
996 ‎‡2 ISNI|0000000077031842
996 ‎‡2 BNC|981058614404606706
996 ‎‡2 ISNI|0000000035436956
996 ‎‡2 BNE|XX1411043
996 ‎‡2 LC|n 84172974
996 ‎‡2 ISNI|0000000047432549
996 ‎‡2 BNF|13492756
996 ‎‡2 SUDOC|237247607
996 ‎‡2 LC|n 50042800
996 ‎‡2 LC|n 2019062232
996 ‎‡2 LC|n 2012028216
996 ‎‡2 DNB|1130725790
996 ‎‡2 ISNI|000000006150473X
996 ‎‡2 NUKAT|n 97035533
996 ‎‡2 RERO|A010057518
996 ‎‡2 NUKAT|n 2006141022
996 ‎‡2 LC|n 2001008727
996 ‎‡2 RERO|A027538563
996 ‎‡2 DNB|173202144
996 ‎‡2 DNB|1162295384
996 ‎‡2 PTBNP|1359014
996 ‎‡2 LC|n 2007067232
996 ‎‡2 J9U|987011542575105171
996 ‎‡2 NUKAT|n 2010103676
996 ‎‡2 NKC|mzk2015880878
996 ‎‡2 ISNI|0000000083032411
996 ‎‡2 BIBSYS|90531943
996 ‎‡2 BNE|XX1212844
996 ‎‡2 ISNI|0000000102009234
996 ‎‡2 JPG|500282181
996 ‎‡2 LC|no2004072930
996 ‎‡2 J9U|987007394709505171
996 ‎‡2 CAOONL|ncf11252465
996 ‎‡2 SELIBR|194551
996 ‎‡2 DNB|133386090
996 ‎‡2 BIBSYS|90317332
996 ‎‡2 LC|nr 95009040
996 ‎‡2 ISNI|0000000397062381
996 ‎‡2 ISNI|0000000403056667
996 ‎‡2 DE633|pe30005340
996 ‎‡2 PLWABN|9810562729305606
996 ‎‡2 BNF|16222639
996 ‎‡2 ISNI|0000000081905856
996 ‎‡2 SUDOC|030576474
996 ‎‡2 BAV|495_234871
996 ‎‡2 NYNYRILM|196433
996 ‎‡2 NTA|072288876
996 ‎‡2 ISNI|0000000372678323
996 ‎‡2 J9U|987007449347805171
996 ‎‡2 DNB|1096203669
996 ‎‡2 LC|n 2013181368
996 ‎‡2 RERO|A014055625
996 ‎‡2 ISNI|0000000424392686
996 ‎‡2 NUKAT|n 2022164228
996 ‎‡2 BNF|12382168
996 ‎‡2 DNB|105308045X
996 ‎‡2 J9U|987007424179205171
996 ‎‡2 LC|nr2004013371
996 ‎‡2 SUDOC|16111881X
996 ‎‡2 J9U|987007448812905171
996 ‎‡2 LC|n 2014043891
996 ‎‡2 LC|no2018126170
996 ‎‡2 BIBSYS|13021673
996 ‎‡2 BNC|981058520400506706
996 ‎‡2 LC|n 96019435
996 ‎‡2 ISNI|0000000064035393
996 ‎‡2 ISNI|0000000401660916
996 ‎‡2 DNB|104797522X
996 ‎‡2 LC|no2020047769
996 ‎‡2 ISNI|0000000032115284
996 ‎‡2 LC|n 87817181
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏